Persistent intracranial hyper-inflammation in ruptured cerebral aneurysm after COVID-19: case report and review of the literature.
Cerebral aneurysm
IL-6
Posterior cerebral artery
SARS-CoV-2
Subarachnoid hemorrhage
Journal
BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555
Informations de publication
Date de publication:
02 Jan 2024
02 Jan 2024
Historique:
received:
12
07
2023
accepted:
06
12
2023
medline:
4
1
2024
pubmed:
4
1
2024
entrez:
3
1
2024
Statut:
epublish
Résumé
The systemic manifestations of coronavirus disease 2019 (COVID-19) include hyperinflammatory reactions in various organs. Recent studies showed evidence for the frequent involvement of central nervous system in affected patients; however, little is known about clinical features of cerebrovascular diseases in childhood-onset COVID-19. A 10-year-old boy recovered from SARS-CoV-2 infection without complication. On 14 days after infection, he presented with loss of consciousness. A head computed tomography detected a ruptured cerebral aneurysm at the left posterior cerebral artery accompanying subarachnoid hemorrhage (SAH). Immediate surgical intervention did not rescue the patient, resulting in the demise 7 days after admission. Serological and genetic tests excluded the diagnosis of vasculitis and connective tissue disorders. Retrospective analysis showed markedly higher levels of interleukin (IL)-1β, IL-6 and IL-8 in the cerebrospinal fluid than the serum sample concurrently obtained. A review of literature indicated that adult patients with COVID-19 have a risk for the later development of SAH during the convalescent phase of COVID-19. SAH is a severe complication of COVID-19 in children and adults who have asymptomatic cerebrovascular aneurysms. The markedly high levels of cytokines detected in the cerebrospinal fluid suggested that intracranial hyperinflammatory condition might be one of the possible mechanisms involved in the rupture of a preexisting cerebrovascular aneurysms.
Sections du résumé
BACKGROUND
BACKGROUND
The systemic manifestations of coronavirus disease 2019 (COVID-19) include hyperinflammatory reactions in various organs. Recent studies showed evidence for the frequent involvement of central nervous system in affected patients; however, little is known about clinical features of cerebrovascular diseases in childhood-onset COVID-19.
CASE PRESENTATION
METHODS
A 10-year-old boy recovered from SARS-CoV-2 infection without complication. On 14 days after infection, he presented with loss of consciousness. A head computed tomography detected a ruptured cerebral aneurysm at the left posterior cerebral artery accompanying subarachnoid hemorrhage (SAH). Immediate surgical intervention did not rescue the patient, resulting in the demise 7 days after admission. Serological and genetic tests excluded the diagnosis of vasculitis and connective tissue disorders. Retrospective analysis showed markedly higher levels of interleukin (IL)-1β, IL-6 and IL-8 in the cerebrospinal fluid than the serum sample concurrently obtained. A review of literature indicated that adult patients with COVID-19 have a risk for the later development of SAH during the convalescent phase of COVID-19.
CONCLUSIONS
CONCLUSIONS
SAH is a severe complication of COVID-19 in children and adults who have asymptomatic cerebrovascular aneurysms. The markedly high levels of cytokines detected in the cerebrospinal fluid suggested that intracranial hyperinflammatory condition might be one of the possible mechanisms involved in the rupture of a preexisting cerebrovascular aneurysms.
Identifiants
pubmed: 38166683
doi: 10.1186/s12883-023-03493-z
pii: 10.1186/s12883-023-03493-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
17Subventions
Organisme : Japan Society for the Promotion of Science
ID : JP19K10613
Organisme : Ministry of Health, Labour and Welfare
ID : 22HA1003
Organisme : Ministry of Health, Labour and Welfare
ID : JP20FC1054
Organisme : Japan Agency for Medical Research and Development
ID : JP20ek0109411, JP20wm0325002h
Informations de copyright
© 2023. The Author(s).
Références
World Health Organization. WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int . Accessed 27 March 2023.
Elrobaa IH, New KJ. COVID-19: pulmonary and extra pulmonary manifestations. Front Public Health. 2021;9:711616.
doi: 10.3389/fpubh.2021.711616
pubmed: 34650947
pmcid: 8505777
LaRovere KL, Riggs BJ, Poussaint TY, Young CC, Newhams MM, Maamari M, et al. Neurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or multisystem inflammatory syndrome. JAMA Neurol. 2021;78:536–47.
doi: 10.1001/jamaneurol.2021.0504
pubmed: 33666649
Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the nervous system. Cell. 2020;183:16-27.e1.
doi: 10.1016/j.cell.2020.08.028
pubmed: 32882182
pmcid: 7437501
Margos NP, Meintanopoulos AS, Filioglou D, Ellul J. Intracerebral hemorrhage in COVID-19: a narrative review. J Clin Neurosci. 2021;89:271–8.
doi: 10.1016/j.jocn.2021.05.019
pubmed: 34119280
pmcid: 8096173
Nannoni S, de Groot R, Bell S, Markus HS. Stroke in COVID-19: a systematic review and meta-analysis. Int J Stroke. 2021;16:137–49.
doi: 10.1177/1747493020972922
pubmed: 33103610
Fiani B, Fowler JB, Figueras RA, Hessamian K, Mercado N, Vukcevich O, et al. Ruptured cerebral aneurysms in COVID-19 patients: a review of literature with case examples. Surg Neurol Int. 2021;12:187.
doi: 10.25259/SNI_214_2021
pubmed: 34084615
pmcid: 8168707
Khan D, Naderi S, Ahmadi M, Ghorbani A, Cornelius JF, Hänggi D, et al. Intracranial aneurysm rupture after SARS-CoV2 infection: case report and review of literature. Pathogens. 2022;11(6):617.
doi: 10.3390/pathogens11060617
pubmed: 35745471
pmcid: 9227511
Dodd WS, Jabbour PM, Sweid A, Tjoumakaris S, Gooch MR, Al Saiegh F, et al. Aneurysmal subarachnoid hemorrhage in patients with coronavirus disease 2019 (COVID-19): a case series. World Neurosurg. 2021;153:e259–64.
doi: 10.1016/j.wneu.2021.06.092
pubmed: 34242830
pmcid: 8260497
Leber AL, Everhart K, Balada-Llasat JM, Cullison J, Daly J, Holt S, et al. Multicenter evaluation of BioFire FilmArray Meningitis/Encephalitis panel for detection of bacteria, viruses, and yeast in cerebrospinal fluid specimens. J Clin Microbiol. 2016;54:2251–61.
doi: 10.1128/JCM.00730-16
pubmed: 27335149
pmcid: 5005480
Ieda D, Hori I, Nakamura Y, Ohshita H, Negishi Y, Shinohara T, et al. A novel truncating mutation in FLNA causes periventricular nodular heterotopia, Ehlers-Danlos-like collagenopathy and macrothrombocytopenia. Brain Dev. 2018;40:489–92.
doi: 10.1016/j.braindev.2018.01.010
pubmed: 29449050
Savić D, Alsheikh TM, Alhaj AK, Lazovic L, Alsarraf L, Bosnjakovic P, et al. Ruptured cerebral pseudoaneurysm in an adolescent as an early onset of COVID-19 infection: case report. Acta Neurochir (Wien). 2020;162:2725–9.
doi: 10.1007/s00701-020-04510-7
pubmed: 32720013
Sweid A, Hammoud B, Bekelis K, Missios S, Tjoumakaris SI, Gooch MR, et al. Cerebral ischemic and hemorrhagic complications of coronavirus disease 2019. Int J Stroke. 2020;15:733–42.
doi: 10.1177/1747493020937189
pubmed: 32501751
pmcid: 7534206
Muhammad S, Petridis A, Cornelius JF, Hänggi D. Letter to editor: severe brain haemorrhage and concomitant COVID-19 Infection: a neurovascular complication of COVID-19. Brain Behav Immun. 2020;87:150–1.
doi: 10.1016/j.bbi.2020.05.015
pubmed: 32387342
pmcid: 7199686
Cezar-Junior AB, Faquini IV, Silva JLJ, de Carvalho Junior EV, Lemos L, Freire Filho JBM, et al. Subarachnoid hemorrhage and COVID-19: association or coincidence? Medicine. 2020;99:e23862.
doi: 10.1097/MD.0000000000023862
pubmed: 33371170
pmcid: 7748374
Al Saiegh F, Ghosh R, Leibold A, Avery MB, Schmidt RF, Theofanis T, et al. Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke. J Neurol Neurosurg Psychiatry. 2020;91:846–8.
doi: 10.1136/jnnp-2020-323522
pubmed: 32354770
Rustemi O, Raneri F, Iannucci G, Volpin L, Segna A. Aneurysmal subarachnoid hemorrhage in a SARS-CoV-2 positive testing: casual or causal? Br J Neurosurg. 2022;36:293–4.
doi: 10.1080/02688697.2020.1787343
pubmed: 32614633
Sato T, Miura Y, Yasuda R, Toma N, Suzuki H. Vertebral artery dissecting aneurysm rupture under severe COVID-19. Brain Hemorrhages. 2022;3:210–3.
doi: 10.1016/j.hest.2022.08.001
pubmed: 35975276
pmcid: 9373470
Etminan N, Chang HS, Hackenberg K, de Rooij NK, Vergouwen MDI, Rinkel GJE, et al. Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis. JAMA Neurol. 2019;76:588–97.
doi: 10.1001/jamaneurol.2019.0006
pubmed: 30659573
pmcid: 6515606
Ciceri EF, Klucznik RP, Grossman RG, Rose JE, Mawad ME. Aneurysms of the posterior cerebral artery: classification and endovascular treatment. AJNR Am J Neuroradiol. 2001;22:27–34.
pubmed: 11158883
pmcid: 7975554
Panther EJ, Lucke-Wold B. Subarachnoid hemorrhage: management considerations for COVID-19. Explor Neuroprotective Ther. 2022;2:65–73.
doi: 10.37349/ent.2022.00018
pubmed: 35340712
pmcid: 8951071
Cañas CA, Cañas F, Bautista-Vargas M, Bonilla-Abadía F. Role of tissue factor in the pathogenesis of COVID-19 and the possible ways to inhibit it. Clin Appl Thromb Hemost. 2021;27:10760296211003983.
doi: 10.1177/10760296211003983
pubmed: 33784877
pmcid: 8020089
Kafadar S, Yucetas SC, Gezgin I, Kaya H, Gulacti U, Bilek O. Influence of COVID-19 disease on subarrachnoid hemorrhage and intracerebral hemorrhage. Bratisl Lek Listy. 2022;123:140–3.
pubmed: 35065591
Qureshi AI, Baskett WI, Huang W, Shyu D, Myers D, Labanova I, et al. Subarachnoid hemorrhage and COVID-19: an analysis of 282,718 patients. World Neurosurg. 2021;151:e615–20.
doi: 10.1016/j.wneu.2021.04.089
pubmed: 33940263
pmcid: 8086384
Ridwan S, Grote A, Simon M. Interleukin 6 in cerebrospinal fluid is a biomarker for delayed cerebral ischemia (DCI) related infarctions after aneurysmal subarachnoid hemorrhage. Sci Rep. 2021;11:12.
doi: 10.1038/s41598-020-79586-3
pubmed: 33420113
pmcid: 7794326
Jarius S, Pache F, Kortvelyessy P, Jelcic I, Stettner M, Franciotta D, et al. Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients. J Neuroinflammation. 2022;19:19.
doi: 10.1186/s12974-021-02339-0
pubmed: 35057809
pmcid: 8771621